PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. It holds the intellectual property rights related to the production, marketing and distribution of Sucanon, a oral treatment for type II diabetes. The company was founded on December 11, 2000 and is headquartered in Las Vegas, NV.